NextBio has entered into a major licensing agreement with Johnson & Johnson for use of NextBio's innovative life sciences search engine and collaboration platform. NextBio is being used by researchers and clinicians at Johnson & Johnson Pharmaceutical R&D, Tibotec Therapeutics and Centocor.
Subscribe to our email newsletter
NextBio is a search engine that enables researchers and clinicians to access and understand the world’s life sciences information to find important new correlations, make discoveries, and generate hypotheses as never before.
Saeid Akhtari, NextBio’s president and CEO, said: “This agreement is a milestone for NextBio. We are seeing major validation of our software as a service (SaaS) model as leading enterprises securely integrate and search their internal data using our innovative search engine.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.